CCL3 and CCL4 are chemokines contributing to the remodeling of the CLL microenvironment, are important biomarkers for BCR activation and correlate with poor prognostic markers for CLL progression [71, 72]. Here, CCL4 is linked to B-cell chronic lymphocytic leukemia.